FDA Inspection 1210012 - Aspire Fertility Institute Dallas - July 12, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Aspire Fertility Institute Dallas, with an inspection on July 12, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Aspire Fertility Institute Dallas
Inspection Date: July 12, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 51fa9474-660d-4a1e-9e31-9eb97042cd5b

Violation Codes2

21 CFR 1271.50(a)21 CFR 1271.55(b)(1)

Full citation text and observation details available on the Dashboard.